Paraguay vs Trinidad and Tobago: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Paraguay
91.0%
in 2024
Trinidad and Tobago
91.0%
in 2024
Paraguay rank
52nd
Trinidad and Tobago rank
52nd
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Paraguay
- Trinidad and Tobago
How they compare
Paraguay currently reports 91.0% against 91.0% in Trinidad and Tobago, a difference of 0.0%.
The two have swapped places 3 times across 13 shared years of data; in 2012 it was Paraguay ahead.
Paraguay ranks 52nd and Trinidad and Tobago ranks 52nd of 146 countries.
Across the 2 decades both report, Paraguay averaged higher in 1 and Trinidad and Tobago in 1.
Head to head by decade
| Decade | Paraguay | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 90.4% | 85.5% | 4.9% | Paraguay |
| 2020s | 77.2% | 93.6% | 16.4% | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Paraguay or Trinidad and Tobago?
- Paraguay, at 91.0% against 91.0% in Trinidad and Tobago as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Paraguay and Trinidad and Tobago?
- 0.0%, with Paraguay ahead.
- How many years of comparable data are there for Paraguay and Trinidad and Tobago?
- 13 years are reported by both, from 2012 to 2024.
- How do Paraguay and Trinidad and Tobago rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Paraguay ranks 52nd and Trinidad and Tobago ranks 52nd of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.